Choose from Ovarian Cancer Treatment stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing ...

Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection. Increased awareness of symptoms like persistent bloating and pelvic ...

AJMC Insights Series features Kathleen Moore, MD, MS, a gynecologic oncologist and expert in ovarian cancer treatment. Dr Moore discusses various aspects of novel therapies for ovarian cancer ...

Patients treated with pembrolizumab plus paclitaxel with or without bevacizumab had a statistically significant and clinically meaningful improvement in PFS, regardless of PD-L1 status. Topline ...

Since she enrolled in a clinical trial at MSK to treat her low-grade serous ovarian cancer, Ellen Coopersmith has a new outlook on life. The first drug for a rare and difficult-to-treat type of ...

High-risk advanced ovarian cancer patients showed marginal survival benefit with bevacizumab added to first-line chemotherapy. Patients without high-risk characteristics did not show significant ...

Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women over 50. Screening is highly recommended in women with ...

AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...

Matulonis, MD, shares that although data from the REFRaME-O1 trial of luveltamab tazevibulin were presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, the agent’s ...

Huntsville Hospital Foundation invites creatives to design the 2025 Liz Hurley Ribbon Run T-shirt, promoting breast cancer ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).